Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for Child Survival in Niger (AVENIR)
NCT05288023Phase 4Terminated
- Sponsor
- University of California, San Francisco
- Start
- Dec 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in child mortality (U5MR), sponsored by University of California, San Francisco. Started Dec 2022; status: terminated.
02
Drugs
azithromycin
03
Conditions
child mortality (U5MR)
Beyond the preview
Go deeper on NCT05288023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05288023.